Which Magnesium Is Best for Vertigo?

Magnesium citrate is the form with the best combination of research backing and bioavailability for most vertigo-related conditions, but the honest answer is more layered than a single recommendation. “Vertigo” is not one disease. It is a symptom shared by conditions as different as benign paroxysmal positional vertigo (BPPV), vestibular migraine, and Ménière’s disease, and each involves magnesium through a slightly different pathway. The form that serves you best depends on which type of vertigo you have, whether you are trying to prevent episodes or manage acute ones, and how well your body absorbs what you take.

Why Magnesium Keeps Coming Up in Vertigo Conversations

Magnesium is involved in hundreds of enzymatic reactions in the body, but its relevance to vertigo comes down to a few specific roles. It regulates calcium movement in and out of cells, stabilizes nerve signaling, influences blood-vessel tone, and participates in the formation of tiny calcium carbonate crystals in the inner ear called otoconia. When those crystals become dislodged and float into the wrong part of the semicircular canals, the result is BPPV, the most common cause of positional vertigo. Research has found that magnesium is essential for the normal development and integrity of these crystals, and that an imbalanced ratio of calcium to magnesium in the blood appears to raise the risk of BPPV.¹

In vestibular migraine, a different mechanism is at work. Magnesium deficiency promotes a wave of abnormal electrical activity in the brain called cortical spreading depression, which is considered a key trigger for migraine attacks, including the vestibular variety that produces dizziness and spinning sensations.² And in conditions involving hearing loss and vertigo together, such as Ménière’s disease, magnesium’s ability to counteract vasospasm in the small blood vessels of the inner ear may play a protective role.³

In severe cases of magnesium depletion, vertigo and visual disturbances can appear directly. Clinical reports have documented patients with serum magnesium below 1.0 mg/dL who developed downbeat nystagmus and oscillopsia, a sensation that the visual world is bouncing. Their symptoms were traced to magnesium depletion rather than any structural neurological disease.⁴ That level of deficiency is uncommon in the general population, but subclinical shortfalls are widespread and may contribute to vertigo susceptibility in subtler ways.

Magnesium Citrate Has the Strongest Case

If you are looking for one form to start with, magnesium citrate is the safest bet for general vertigo prevention. It consistently outperforms magnesium oxide in absorption studies. In a controlled comparison measuring urinary magnesium excretion after equal oral doses, citrate produced a dramatically higher magnesium rise than oxide, confirming it is far more bioavailable.⁵ That matters because a supplement you cannot absorb is essentially a placebo with side effects.

Citrate is also the form most directly studied in vestibular migraine. It has been used in prophylaxis trials for both children and adults with migraine-related dizziness, and a narrative review of magnesium in otology noted that roughly 400 mg of oral magnesium daily is the dose used for prophylaxis of vestibular conditions.² An observational study of 82 vestibular migraine patients treated with nonprescription therapies including magnesium found that about half showed meaningful improvement in symptom severity and frequency, with dizziness handicap scores dropping by roughly 44%.⁶ That is not a randomized controlled trial, so the numbers should be taken with caution, but the direction of the evidence is encouraging.

Citrate is widely available, relatively inexpensive, and generally well tolerated. Its main drawback is that at higher doses it can loosen stools, which is why it is also sold as a laxative in large liquid doses. At the 400 mg per day range used for vertigo prevention, most people tolerate it fine.

Magnesium L-Threonate and the Blood-Brain Barrier

The most interesting newer form for neurological applications is magnesium L-threonate. It was developed specifically to raise magnesium levels in the central nervous system, and animal research has confirmed that it can do something other common forms cannot: increase magnesium concentration in cerebrospinal fluid. In a mouse study comparing threonate with magnesium sulfate, only the threonate form raised brain magnesium levels. The sulfate form, despite being widely used in clinical settings as an intravenous preparation, did not move the needle on cerebrospinal fluid magnesium at all.⁷

This is compelling in theory, because many forms of vertigo originate in the brain or in the vestibular nerve, not just in the inner ear. Vestibular migraine is fundamentally a brain-driven condition. If threonate genuinely delivers more magnesium to neural tissue than citrate does, it could be a better preventive option for migraine-related vertigo specifically. The problem is that this has not been tested in human vertigo trials. The cerebrospinal fluid data comes from animal models, and no study has yet compared threonate head-to-head against citrate for vestibular outcomes in people. It is a reasonable choice if you are already managing migraine-related dizziness and want to try an alternative to citrate, but it is not yet the evidence-based first choice.

Threonate supplements also tend to be more expensive per dose and deliver less elemental magnesium per capsule than citrate, which means you sometimes need more capsules to reach a therapeutic amount. If cost matters to you, that is worth factoring in.

Magnesium Taurate and Glycinate

Magnesium taurate pairs magnesium with the amino acid taurine. The rationale for this combination is primarily cardiovascular: both magnesium and taurine independently help keep intracellular calcium levels in check, relax blood vessels, and stabilize heart rhythm.⁸ If your vertigo has a vascular component, as some clinicians suspect in Ménière’s disease and certain forms of inner-ear blood supply disruption, the combined effect of magnesium and taurine on small blood vessel tone could theoretically help. But the word “theoretically” is doing heavy lifting here. There are no clinical trials of magnesium taurate for vertigo or dizziness. The hypothesis paper proposing it focused on cardiovascular protection, not vestibular disorders.

Magnesium glycinate, another popular option, is valued mainly for its gentle effect on the stomach. It is well absorbed and less likely to cause loose stools than citrate, making it a reasonable alternative for people who find citrate too hard on the gut. Like taurate, it has no direct vertigo research behind it. Its advantage is tolerability, not superior evidence for dizziness.

The One Form to Avoid

Magnesium oxide is the most commonly sold form on store shelves, and it is also the worst absorbed. The bioavailability comparison between oxide and citrate found that citrate produced a urinary magnesium rise roughly 37 times higher than oxide over the first four hours after ingestion.⁵ Oxide looks attractive on the label because its high elemental magnesium content means a single tablet often claims 400 mg or more, but much of that passes through you unabsorbed. If you have been taking magnesium oxide for vertigo and not noticing any benefit, the form itself might be the issue before you conclude magnesium does not work for you.

Matching Magnesium to Your Type of Vertigo

Not every vertigo condition responds to magnesium the same way, and being specific about what you are treating helps you choose the right form and set realistic expectations.

Vestibular migraine: This is where the evidence is most encouraging. Oral magnesium at around 400 mg daily is used as a preventive strategy, and citrate is the form with the most research behind it for this purpose. If you get migraines that come with dizziness, spinning, or motion intolerance rather than just headache, magnesium supplementation is a reasonable first-line approach that many neurologists recommend before jumping to prescription drugs.
BPPV: The link between magnesium and BPPV is real but indirect. Research has found that patients with BPPV tend to show a disturbed calcium-to-magnesium ratio in their blood, and that a lower ratio was associated with roughly four times the odds of having the condition.¹ That said, the primary treatment for BPPV is the Epley maneuver or similar repositioning techniques. Magnesium supplementation might reduce recurrence by supporting healthy otoconia, but it will not replace mechanical treatment of an active episode.
Ménière’s disease: Magnesium’s role here is more speculative, centered on its ability to reduce vasospasm in inner ear blood vessels. The clinical evidence for oral magnesium in Ménière’s is thin, and reviews of Ménière’s trials have noted a large placebo response rate, with over half of placebo-group patients reporting fewer vertigo episodes.⁹ That high placebo response makes it difficult to know whether supplements are genuinely helping or whether the natural fluctuation of the disease is doing the work.
Anxiety-driven dizziness: Persistent postural-perceptual dizziness (PPPD) and chronic subjective dizziness are often intertwined with anxiety. Magnesium deficiency has been shown to increase anxiety-like behavior and dysregulate the stress-hormone axis in animal models.¹⁰ If your dizziness worsens with stress or feels untethered from any obvious inner-ear trigger, correcting a magnesium shortfall could help with the anxiety component, which may in turn reduce dizziness. Glycinate and threonate are popular choices here because of their calming reputation, though formal trials in this specific context are lacking.

Dosing and What to Watch For

The dose that shows up most often in vertigo-related research is around 400 mg of elemental magnesium per day taken orally, which aligns with what a narrative review of magnesium in otology recommended for prophylaxis of vestibular conditions. For acute situations in clinical settings, intravenous magnesium sulfate at 1 to 2 grams has been used, but that is a hospital intervention, not something to replicate at home.

The current tolerable upper intake level set by the U.S. Institute of Medicine for supplemental magnesium is 350 mg per day, based primarily on diarrhea as the limiting side effect. However, a recent re-evaluation of the evidence found that across multiple studies testing supplemental doses ranging from 128 to 1,200 mg daily, there was no significant difference in diarrhea between the supplement and placebo groups.¹¹ In practice, many people tolerate 400 to 500 mg of supplemental magnesium daily without trouble, especially if they split it across two doses and take it with food. If you have kidney disease, though, magnesium clearance is impaired and supplementation requires medical supervision.

It is worth noting that magnesium from food does not count toward the upper limit. Foods like pumpkin seeds, almonds, spinach, and dark chocolate are high in magnesium, and dietary intake works alongside supplementation. If you are already eating a magnesium-rich diet, you may need a smaller supplement dose to reach a beneficial level.

How Long Before You Notice Anything

One of the most common frustrations with magnesium supplementation for vertigo is that it takes time. Unlike a repositioning maneuver for BPPV that can resolve symptoms in minutes, or a medication like meclizine that suppresses dizziness within an hour, magnesium works preventively. Most migraine prophylaxis studies run for at least eight to twelve weeks before measuring outcomes. If you start magnesium citrate at 400 mg per day and feel no different after two weeks, that is not a failure of the supplement. It means you have not given it enough time.

It also helps to know what success looks like. In vestibular migraine, the goal is usually fewer and less severe episodes, not the complete elimination of all dizziness. The observational data showing a roughly 44% improvement in symptom scores is meaningful, but it also means more than half of the original symptom burden remained.⁶ Magnesium is rarely a complete solution on its own, but it can be a worthwhile piece of a broader management strategy.

The Placebo Problem in Vertigo Research

Vertigo is subjective. You cannot measure it with a blood test or an imaging scan in the way you would confirm a broken bone. Most vertigo research relies on patient-reported questionnaires, which are susceptible to placebo effects. This matters when evaluating any supplement, including magnesium. In Ménière’s disease trials specifically, a meta-analysis found that about 52.5% of patients in placebo groups reported improvement in vertigo episodes.⁹ That is a strikingly high placebo response. When more than half of people taking a sugar pill feel better, it raises the bar considerably for any treatment to prove it works beyond expectation and natural fluctuation.

This does not mean magnesium is useless for vertigo. It means the evidence is still evolving, and the strongest case exists for vestibular migraine rather than for all dizziness conditions lumped together. It also means that individual testimonials about dramatic improvement on magnesium are hard to interpret. Some of that improvement is real pharmacological effect, and some of it is the natural waxing and waning of vertigo conditions combined with the hope of having found a solution. The distinction between the two requires controlled trials, and for most magnesium forms and most vertigo subtypes, those trials have not yet been done.

When Magnesium Is Not the Answer

Magnesium supplementation makes sense when vertigo is chronic, recurrent, and linked to a condition known to involve magnesium physiology. It does not make sense as a first response to a single, sudden episode of severe vertigo. New-onset vertigo, especially if accompanied by hearing loss, severe headache, difficulty speaking or walking, or numbness, warrants prompt medical evaluation because those symptoms can indicate stroke, acoustic neuroma, or other conditions where supplements are irrelevant and delays are dangerous.

Even among chronic vertigo sufferers, magnesium is not a universal fix. If your dizziness is caused by vestibular neuritis (a viral inflammation of the balance nerve), magnesium has no established role. If it is caused by a perilymph fistula or superior canal dehiscence, those are structural problems that sometimes require surgical repair. Magnesium is a reasonable tool in the right clinical context, but vertigo is one of the most diagnostically tricky symptoms in medicine. Getting the right diagnosis first makes the difference between supplementing intelligently and guessing in the dark.

1
Auditory and Vestibular Research. Blood Serum Levels of Magnesium in Patients with Benign Paroxysmal Positional Vertigo
2
Audiologia e Foniatria. Use of magnesium citrate in the prophylaxis of vestibular migraine in childhood
3
PubMed Central. Evidence Supporting the Hypothesis That Inflammation-Induced Vasospasm Is Involved in the Pathogenesis of Acquired Sensorineural Hearing Loss
4
JAMA Neurology. Downbeat Nystagmus With Magnesium Depletion
5
PubMed. Magnesium bioavailability from magnesium citrate and magnesium oxide
6
PubMed. Effects of nonprescription therapies on vestibular migraine: a questionnaire-based observational study
7
PubMed Central. Treatment Of Magnesium-L-Threonate Elevates The Magnesium Level In The Cerebrospinal Fluid And Attenuates Motor Deficits And Dopamine Neuron Loss In A Mouse Model Of Parkinson’s disease
8
PubMed. Complementary vascular-protective actions of magnesium and taurine: a rationale for magnesium taurate
9
ScienceDirect / Elsevier (Am J Otolaryngol). Placebo effect in randomized controlled trials for Meniere’s disease: A meta-analysis
10
PubMed Central. Magnesium deficiency induces anxiety and HPA axis dysregulation: modulation by therapeutic drug treatment
11
PubMed Central. Call for Re-evaluation of the Tolerable Upper Intake Level for Magnesium Supplementation in Adults